Mario Karolyi, Sara Omid, Erich Pawelka, Bernd Jilma, Thomas Stimpfl, Christian Schoergenhofer, . . . Alexander Zoufaly. (2021). High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMario Karolyi, et al. High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationMario Karolyi, et al. High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.